MTOR and non-small cell lung carcinoma: NDUFA9 was identified as a positive regulator of the Akt-mTOR signaling pathway; its depletion inhibited, and its overexpression enhanced, mTOR kinase activity and the phosphorylation of Akt and S6K in primary NSCLC cells.